148 results
8-K
IMNM
Immunome, Inc.
13 Jun 24
Submission of Matters to a Vote of Security Holders
4:05pm
, Ph.D.
Carol A. Schafer
Proposal 2: Ratification of Selection of Independent Registered Public Accounting Firm
The Company’s stockholders ratified … the selection by the Audit Committee of the Company’s Board of Directors of Ernst & Young LLP as the Company’s independent registered public
424B5
IMNM
Immunome, Inc.
14 May 24
Prospectus supplement for primary offering
8:48am
independent registered public accounting firm under Section 404 of the Sarbanes-Oxley Act of 2002, or
S-1
the Sarbanes-Oxley Act, reduced disclosure … and therein also contain estimates and other statistical data made by independent parties and by us relating to market size and growth and other data about
DEFA14A
ertzmh u7rn2isg
26 Apr 24
Additional proxy soliciting materials
4:08pm
S-3ASR
ah4 bydjmya0v
3 Apr 24
Automatic shelf registration
4:40pm
S-3ASR
EX-23.1
vsp c5rdno7lxz
3 Apr 24
Automatic shelf registration
4:40pm
S-3ASR
EX-23.1
swns6n
3 Apr 24
Automatic shelf registration
4:36pm
S-3ASR
3unjtl8l91a
3 Apr 24
Automatic shelf registration
4:36pm
8-K
EX-10.1
ydjrm1bf
26 Mar 24
Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala
8:05am
8-K
EX-1.1
ugd5cnaof i6
14 Feb 24
Other Events
4:11pm
424B5
qwlup558yddowdnjwit
14 Feb 24
Prospectus supplement for primary offering
4:09pm